{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T09:18:44Z","timestamp":1787649524967,"version":"build-2736575974"},"reference-count":39,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: To evaluate the prognostic significance of the novel hemoglobin\u2013albumin\u2013C-reactive protein (HARP) index in patients with locally advanced nasopharyngeal carcinoma (LANPC) treated with definitive concurrent chemoradiotherapy (CCRT). Methods: This retrospective study included 248 patients with LANPC treated with definitive CCRT between 2011 and 2020. The HARP index [hemoglobin \u00d7 (albumin \u00f7 C-reactive protein)] was calculated using pretreatment laboratory values. Prognostic associations between HARP and survival outcomes were evaluated using continuous and categorical Cox regression analyses, restricted cubic spline modeling, receiver operating characteristic analyses, and bootstrap-based internal validation. Results: Lower pretreatment HARP values were independently associated with inferior progression-free survival (PFS) and overall survival (OS). In continuous Cox analyses, increasing HARP values were associated with reduced risks of mortality and disease progression (both p &lt; 0.001). ROC analysis identified 3.2 as the exploratory cut-off value for clinical stratification. Patients with HARP \u2265 3.2 (n = 112) had significantly better outcomes than those with HARP &lt; 3.2 (n = 136). Median PFS and OS were not reached in the high-HARP group, whereas they were 47.0 and 72.0 months, respectively, in the low-HARP group. Low HARP values were associated with inferior PFS (HR, 3.86; p &lt; 0.001) and OS (HR, 3.06; p &lt; 0.001). Bootstrap internal validation demonstrated stable model discrimination with minimal optimism. Conclusions: The novel HARP index is an independently associated and internally validated prognostic biomarker in patients with LANPC treated with definitive CCRT. HARP may provide a practical tool for improved risk stratification, pending prospective external validation.<\/jats:p>","DOI":"10.3390\/diseases14090306","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:00:48Z","timestamp":1787644848000},"page":"306","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The HARP (Hemoglobin\u2013Albumin\u2013C-Reactive Protein) Index: A Biologically Designed Composite Biomarker for Continuous Prognostic Modeling in Locally Advanced Nasopharyngeal Carcinoma"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8120-7123","authenticated-orcid":false,"given":"Erkan","family":"Topkan","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Faculty of Medicine, Ba\u015fkent University, Adana 01250, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-6913","authenticated-orcid":false,"given":"Efsun","family":"Somay","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Ba\u015fkent University, Ankara 06540, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0225-2477","authenticated-orcid":false,"given":"Sibel","family":"Bascil","sequence":"additional","affiliation":[{"name":"Department of Periodontology, Faculty of Dentistry, Ba\u015fkent University, Ankara 06540, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3265-2797","authenticated-orcid":false,"given":"Duriye","family":"Ozturk","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, School of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-3140","authenticated-orcid":false,"given":"Ugur","family":"Selek","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, School of Medicine, Ko\u00e7 University, Istanbul 34330, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s11864-023-01083-2","article-title":"Early stage and locally advanced nasopharyngeal carcinoma treatment from present to future: Where are we and where are we going?","volume":"24","author":"Afkhami","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.06.037","article-title":"Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients","volume":"64","author":"Baujat","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejca.2019.07.007","article-title":"Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase III multicentre randomised controlled trial","volume":"119","author":"Yang","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","article-title":"Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival","volume":"21","author":"Lin","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cncr.29795","article-title":"Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy","volume":"122","author":"Pan","year":"2016","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.oraloncology.2017.12.004","article-title":"Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)","volume":"77","author":"Au","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chiang, C.L., Guo, Q., Ng, W.T., Lin, S., Ma, T.S.W., Xu, Z., Xiao, Y., Li, J., Lu, T., and Choi, H.C.W. (2021). Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM staging by UICC: A systematic review of the literature. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.703995"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7150\/ijbs.24374","article-title":"Prognostic nomogram for patients with nasopharyngeal carcinoma incorporating hematological biomarkers and clinical characteristics","volume":"14","author":"Li","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejca.2011.09.004","article-title":"To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area","volume":"48","author":"Jin","year":"2012","journal-title":"Eur. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1159\/000341827","article-title":"Prognostic role of serum cytokines in patients with nasopharyngeal carcinoma","volume":"35","author":"Lu","year":"2012","journal-title":"Onkologie"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1724600818821688","article-title":"Baseline hemoglobin <11.0 g\/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy","volume":"34","author":"Topkan","year":"2019","journal-title":"Int. J. Biol. Markers"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3127275","DOI":"10.1155\/2020\/3127275","article-title":"Low advanced lung cancer inflammation index predicts poor prognosis in locally advanced nasopharyngeal carcinoma patients treated with definitive concurrent chemoradiotherapy","volume":"2020","author":"Topkan","year":"2020","journal-title":"J. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/CMAR.S155604","article-title":"High C-reactive protein\/albumin ratio predicts unfavorable distant metastasis-free survival in nasopharyngeal carcinoma: A propensity score-matched analysis","volume":"10","author":"Wang","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.7150\/jca.16210","article-title":"The C-reactive protein\/albumin ratio is an independent prognostic factor for overall survival in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy","volume":"7","author":"Tao","year":"2016","journal-title":"J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e11574","DOI":"10.1097\/MD.0000000000011574","article-title":"Prognostic value of pretreatment C-reactive protein\/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature","volume":"97","author":"Yang","year":"2018","journal-title":"Medicine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/ijc.28112","article-title":"Head and neck cancer: From anatomy to biology","volume":"133","author":"Bose","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2174\/187152008785914798","article-title":"Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression","volume":"8","author":"Cosse","year":"2008","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00066-006-1543-7","article-title":"Impact of hemoglobin levels on tumor oxygenation: The higher, the better?","volume":"182","author":"Vaupel","year":"2006","journal-title":"Strahlenther. Onkol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00066-003-1117-x","article-title":"Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors","volume":"179","author":"Micke","year":"2003","journal-title":"Strahlenther. Onkol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0360-3016(97)00101-6","article-title":"Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck","volume":"38","author":"Brizel","year":"1997","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijrobp.2008.04.079","article-title":"Effect of pretreatment anemia on treatment outcome of concurrent radiochemotherapy in patients with head and neck cancer","volume":"72","author":"Fortin","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J. Nucl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00432-017-2360-3","article-title":"The value of the Prognostic Nutritional Index (PNI) in predicting outcomes and guiding the treatment strategy of nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy (IMRT) with or without chemotherapy","volume":"143","author":"Miao","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Hirahara, N., Matsubara, T., Kaji, S., Yamamoto, T., Hyakudomi, R., Takai, K., Ishitobi, K., Uchida, Y., and Tajima, Y. (2021). Phase II feasibility study of adjuvant chemotherapy with docetaxel\/cisplatin\/S-1 followed by S-1 for stage III gastric cancer. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08795-4"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Jiang, Y.-M., Huang, S.-T., Pan, X.-B., Ma, J.-L., and Zhu, X.-D. (2023). The prognostic nutritional index represents a novel inflammation-nutrition-based prognostic factor for nasopharyngeal carcinoma. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1036572"},{"key":"ref_30","first-page":"35","article-title":"Prognostic factors and survival in nasopharyngeal cancer: A single-center experience","volume":"1","author":"Balsak","year":"2024","journal-title":"Int. J. Hematol. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1080\/14737140.2016.1192467","article-title":"Targeting hypoxia to overcome radiation resistance in head & neck cancers: Real challenge or clinical fairytale?","volume":"16","author":"Baumann","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijrobp.2005.04.049","article-title":"Anemia, tumor hypoxemia, and the cancer patient","volume":"63","author":"Varlotto","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.47191\/ijmscrs\/v3-i7-21","article-title":"Effect of baseline hemoglobin level on prognosis in nasopharyngeal cancer patients receiving chemoradiotherapy","volume":"3","author":"Cobanoglu","year":"2023","journal-title":"Int. J. Med. Sci. Clin. Res. Stud."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Guo, S.S., Tang, L.Q., Chen, Q.Y., Zhang, L., Liu, L.T., Huang, P.Y., Cao, K.J., Guo, L., Mo, H.Y., and Guo, X. (2015). Is hemoglobin level in patients with nasopharyngeal carcinoma still a significant prognostic factor in the era of intensity-modulated radiotherapy technology?. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136033"},{"key":"ref_35","first-page":"223","article-title":"Systemic inflammation, nutritional status and survival in patients with cancer","volume":"12","author":"McMillan","year":"2009","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"20229","DOI":"10.1038\/s41598-024-71360-z","article-title":"A scoring system based on inflammatory and nutritional indicators to predict the long-term survival of patients with non-metastatic nasopharyngeal carcinoma","volume":"14","author":"Fang","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e12337","DOI":"10.1097\/MD.0000000000012337","article-title":"Shen-Ling-Bai-Zhu-San for ulcerative colitis","volume":"97","author":"Yang","year":"2018","journal-title":"Medicine"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e8529","DOI":"10.1097\/MD.0000000000008529","article-title":"Anemia and thrombocytopenia as initial symptoms of occult breast cancer with bone marrow metastasis","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Altman, D.G., McShane, L.M., Sauerbrei, W., and Taube, S.E. (2012). Reporting recommendations for tumor marker prognostic studies (REMARK): Explanation and elaboration. BMC Med., 10.","DOI":"10.1186\/1741-7015-10-51"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/9\/306\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:21:08Z","timestamp":1787646068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/9\/306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["diseases14090306"],"URL":"https:\/\/doi.org\/10.3390\/diseases14090306","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}